Literature DB >> 31894638

Genome-wide cfDNA testing of maternal blood.

J C Jani1, M M Gil2, A Benachi3, F Prefumo4, K O Kagan5, A Tabor6, C M Bilardo7, G C Di Renzo8, K H Nicolaides9.   

Abstract

Year:  2020        PMID： 31894638     DOI： 10.1002/uog.21945

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  3 in total

1.  Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.

Authors:  Lisanne van Prooyen Schuurman; Erik A Sistermans; Diane Van Opstal; Lidewij Henneman; Mireille N Bekker; Caroline J Bax; Mijntje J Pieters; Katelijne Bouman; Sonja de Munnik; Nicolette S den Hollander; Karin E M Diderich; Brigitte H W Faas; Ilse Feenstra; Attie T J I Go; Mariëtte J V Hoffer; Marieke Joosten; Fenne L Komdeur; Klaske D Lichtenbelt; Maria P Lombardi; Marike G Polak; Fernanda S Jehee; Heleen Schuring-Blom; Servi J C Stevens; Malgorzata I Srebniak; Ron F Suijkerbuijk; Gita M Tan-Sindhunata; Karuna R M van der Meij; Merel C van Maarle; Vivian Vernimmen; Shama L van Zelderen-Bhola; Nicolien T van Ravesteyn; Maarten F C M Knapen; Merryn V E Macville; Robert-Jan H Galjaard
Journal:  Am J Hum Genet       Date:  2022-06-02       Impact factor: 11.043

2.  Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.

Authors:  Syanni A Kristalijn; Karen White; Deanna Eerbeek; Emilia Kostenko; Francesca Romana Grati; Caterina M Bilardo
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-20       Impact factor: 3.105

Review 3.  Antenatal screening for chromosomal abnormalities.

Authors:  Karl Oliver Kagan; Jiri Sonek; Peter Kozlowski
Journal:  Arch Gynecol Obstet       Date:  2022-03-13       Impact factor: 2.344
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.